1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fully Automated POCT CLIA Analyzer Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Fully Automated POCT CLIA Analyzer by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Fully Automated POCT CLIA Analyzer by Country/Region, 2018, 2022 & 2029
2.2 Fully Automated POCT CLIA Analyzer Segment by Type
2.2.1 Electrochemiluminescence
2.2.2 Direct Chemiluminescence
2.2.3 Enzymatic Chemiluminescence
2.3 Fully Automated POCT CLIA Analyzer Sales by Type
2.3.1 Global Fully Automated POCT CLIA Analyzer Sales Market Share by Type (2018-2023)
2.3.2 Global Fully Automated POCT CLIA Analyzer Revenue and Market Share by Type (2018-2023)
2.3.3 Global Fully Automated POCT CLIA Analyzer Sale Price by Type (2018-2023)
2.4 Fully Automated POCT CLIA Analyzer Segment by Application
2.4.1 Hospital
2.4.2 Medical Examination Institution
2.4.3 Other
2.5 Fully Automated POCT CLIA Analyzer Sales by Application
2.5.1 Global Fully Automated POCT CLIA Analyzer Sale Market Share by Application (2018-2023)
2.5.2 Global Fully Automated POCT CLIA Analyzer Revenue and Market Share by Application (2018-2023)
2.5.3 Global Fully Automated POCT CLIA Analyzer Sale Price by Application (2018-2023)
3 Global Fully Automated POCT CLIA Analyzer by Company
3.1 Global Fully Automated POCT CLIA Analyzer Breakdown Data by Company
3.1.1 Global Fully Automated POCT CLIA Analyzer Annual Sales by Company (2018-2023)
3.1.2 Global Fully Automated POCT CLIA Analyzer Sales Market Share by Company (2018-2023)
3.2 Global Fully Automated POCT CLIA Analyzer Annual Revenue by Company (2018-2023)
3.2.1 Global Fully Automated POCT CLIA Analyzer Revenue by Company (2018-2023)
3.2.2 Global Fully Automated POCT CLIA Analyzer Revenue Market Share by Company (2018-2023)
3.3 Global Fully Automated POCT CLIA Analyzer Sale Price by Company
3.4 Key Manufacturers Fully Automated POCT CLIA Analyzer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fully Automated POCT CLIA Analyzer Product Location Distribution
3.4.2 Players Fully Automated POCT CLIA Analyzer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Fully Automated POCT CLIA Analyzer by Geographic Region
4.1 World Historic Fully Automated POCT CLIA Analyzer Market Size by Geographic Region (2018-2023)
4.1.1 Global Fully Automated POCT CLIA Analyzer Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Fully Automated POCT CLIA Analyzer Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Fully Automated POCT CLIA Analyzer Market Size by Country/Region (2018-2023)
4.2.1 Global Fully Automated POCT CLIA Analyzer Annual Sales by Country/Region (2018-2023)
4.2.2 Global Fully Automated POCT CLIA Analyzer Annual Revenue by Country/Region (2018-2023)
4.3 Americas Fully Automated POCT CLIA Analyzer Sales Growth
4.4 APAC Fully Automated POCT CLIA Analyzer Sales Growth
4.5 Europe Fully Automated POCT CLIA Analyzer Sales Growth
4.6 Middle East & Africa Fully Automated POCT CLIA Analyzer Sales Growth
5 Americas
5.1 Americas Fully Automated POCT CLIA Analyzer Sales by Country
5.1.1 Americas Fully Automated POCT CLIA Analyzer Sales by Country (2018-2023)
5.1.2 Americas Fully Automated POCT CLIA Analyzer Revenue by Country (2018-2023)
5.2 Americas Fully Automated POCT CLIA Analyzer Sales by Type
5.3 Americas Fully Automated POCT CLIA Analyzer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fully Automated POCT CLIA Analyzer Sales by Region
6.1.1 APAC Fully Automated POCT CLIA Analyzer Sales by Region (2018-2023)
6.1.2 APAC Fully Automated POCT CLIA Analyzer Revenue by Region (2018-2023)
6.2 APAC Fully Automated POCT CLIA Analyzer Sales by Type
6.3 APAC Fully Automated POCT CLIA Analyzer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Fully Automated POCT CLIA Analyzer by Country
7.1.1 Europe Fully Automated POCT CLIA Analyzer Sales by Country (2018-2023)
7.1.2 Europe Fully Automated POCT CLIA Analyzer Revenue by Country (2018-2023)
7.2 Europe Fully Automated POCT CLIA Analyzer Sales by Type
7.3 Europe Fully Automated POCT CLIA Analyzer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fully Automated POCT CLIA Analyzer by Country
8.1.1 Middle East & Africa Fully Automated POCT CLIA Analyzer Sales by Country (2018-2023)
8.1.2 Middle East & Africa Fully Automated POCT CLIA Analyzer Revenue by Country (2018-2023)
8.2 Middle East & Africa Fully Automated POCT CLIA Analyzer Sales by Type
8.3 Middle East & Africa Fully Automated POCT CLIA Analyzer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fully Automated POCT CLIA Analyzer
10.3 Manufacturing Process Analysis of Fully Automated POCT CLIA Analyzer
10.4 Industry Chain Structure of Fully Automated POCT CLIA Analyzer
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fully Automated POCT CLIA Analyzer Distributors
11.3 Fully Automated POCT CLIA Analyzer Customer
12 World Forecast Review for Fully Automated POCT CLIA Analyzer by Geographic Region
12.1 Global Fully Automated POCT CLIA Analyzer Market Size Forecast by Region
12.1.1 Global Fully Automated POCT CLIA Analyzer Forecast by Region (2024-2029)
12.1.2 Global Fully Automated POCT CLIA Analyzer Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Fully Automated POCT CLIA Analyzer Forecast by Type
12.7 Global Fully Automated POCT CLIA Analyzer Forecast by Application
13 Key Players Analysis
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.1.3 Roche Diagnostics Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.2.3 Abbott Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Information
13.3.2 Siemens Healthineers Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.3.3 Siemens Healthineers Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Siemens Healthineers Main Business Overview
13.3.5 Siemens Healthineers Latest Developments
13.4 Ortho Clinical Diagnostics
13.4.1 Ortho Clinical Diagnostics Company Information
13.4.2 Ortho Clinical Diagnostics Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.4.3 Ortho Clinical Diagnostics Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ortho Clinical Diagnostics Main Business Overview
13.4.5 Ortho Clinical Diagnostics Latest Developments
13.5 Beckman Coulter
13.5.1 Beckman Coulter Company Information
13.5.2 Beckman Coulter Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.5.3 Beckman Coulter Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beckman Coulter Main Business Overview
13.5.5 Beckman Coulter Latest Developments
13.6 ShenZhen New Industries Biomedical
13.6.1 ShenZhen New Industries Biomedical Company Information
13.6.2 ShenZhen New Industries Biomedical Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.6.3 ShenZhen New Industries Biomedical Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ShenZhen New Industries Biomedical Main Business Overview
13.6.5 ShenZhen New Industries Biomedical Latest Developments
13.7 DiaSorin
13.7.1 DiaSorin Company Information
13.7.2 DiaSorin Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.7.3 DiaSorin Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 DiaSorin Main Business Overview
13.7.5 DiaSorin Latest Developments
13.8 Autobio Diagnostics
13.8.1 Autobio Diagnostics Company Information
13.8.2 Autobio Diagnostics Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.8.3 Autobio Diagnostics Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Autobio Diagnostics Main Business Overview
13.8.5 Autobio Diagnostics Latest Developments
13.9 Tosoh Bioscience
13.9.1 Tosoh Bioscience Company Information
13.9.2 Tosoh Bioscience Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.9.3 Tosoh Bioscience Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Tosoh Bioscience Main Business Overview
13.9.5 Tosoh Bioscience Latest Developments
13.10 Sysmex
13.10.1 Sysmex Company Information
13.10.2 Sysmex Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.10.3 Sysmex Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sysmex Main Business Overview
13.10.5 Sysmex Latest Developments
13.11 Beijing Leadman Biochemistry
13.11.1 Beijing Leadman Biochemistry Company Information
13.11.2 Beijing Leadman Biochemistry Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.11.3 Beijing Leadman Biochemistry Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Beijing Leadman Biochemistry Main Business Overview
13.11.5 Beijing Leadman Biochemistry Latest Developments
13.12 Mindray Bio-Medical
13.12.1 Mindray Bio-Medical Company Information
13.12.2 Mindray Bio-Medical Fully Automated POCT CLIA Analyzer Product Portfolios and Specifications
13.12.3 Mindray Bio-Medical Fully Automated POCT CLIA Analyzer Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Mindray Bio-Medical Main Business Overview
13.12.5 Mindray Bio-Medical Latest Developments
14 Research Findings and Conclusion
※参考情報 全自動式POCT CLIAアナライザーについてご説明いたします。このアナライザーは、ポイント・オブ・ケア(POC)において使用される全自動の化学発光免疫測定法(CLIA)を基盤とした分析装置です。POCT技術は、患者のそばで迅速に検査を行うことができるため、診断や治療の意思決定を迅速にサポートする重要な役割を果たしています。 全自動式POCT CLIAアナライザーは、医療機関や診療所で広く使用されており、主にウイルス感染症、細菌感染症、ホルモン検査、腫瘍マーカー、心筋トロポニンなど、さまざまな検査を一台で行うことができます。このようなアナライザーは、試薬の自動供給、サンプルの自動処理、結果の自動解析ができるため、操作が簡便であり、技術者の負担を大幅に軽減します。 このアナライザーの特徴の一つは、検査結果が迅速に得られる点です。従来のラボ検査と比較して、POCT技術ではサンプル採取から結果が得られるまでの時間が短縮されます。これにより、患者に対する迅速な治療方針の決定が可能となります。また、測定精度においても改善がされており、従来の方法と同等の精度を保ちながら、即時性を追求しています。 全自動式POCT CLIAアナライザーには、さまざまな種類があります。これには、ポータブル型と据え置き型の2つのカテゴリーがあります。ポータブル型は、持ち運びが容易で、巡回診療や災害現場などの特別な環境でも使用されることが多いです。一方で、据え置き型は、大規模な医療機関や研究機関で主に使用され、より多くのサンプル処理能力や追加機能を備えていることが一般的です。 用途の面では、全自動式POCT CLIAアナライザーは、感染症の早期診断に特に有効です。例えば、インフルエンザウイルスや新型コロナウイルス感染症など、迅速な診断が求められる場合において、患者の症状に対して即時に対応できるため、治療開始が速く、市場におけるその重要性が増しています。また、慢性疾患の管理にも利用されており、ホルモンや代謝に関するマーカー測定ができることで、患者の状態を継続的にモニタリングすることが可能です。 関連技術としては、化学発光技術や自動化技術があります。化学発光技術は、分析物と特異的に結合する抗体を用いて、酵素反応を通じて発生する光を測定する方法です。この技術は、高感度かつ高特異性な測定が可能であり、微量の分析物でも検出することができます。自動化技術は、サンプル前処理から結果の報告まで、全てのプロセスを自動で行う性能を持っており、ヒューマンエラーを減少させることに役立っています。 さらに、全自動式POCT CLIAアナライザーは、データ管理機能も持ち合わせています。この機能により、検査結果を電子カルテと連携させたり、クラウド上でのデータ分析が可能になっています。これによって、検査結果のトレンド分析や、大規模な疫学研究への応用も実現します。 全体として、全自動式POCT CLIAアナライザーは、医療現場における迅速な診断を支える重要なツールです。これにより、患者の治療にかかる時間が短縮され、より良い医療サービスが提供されることが期待されています。今後、さらに技術が進化することで、より多くの検査項目がカバーされ、使いやすさや精度も向上していくことでしょう。特に、個別化医療が進む中で、このアナライザーの役割はますます重要になると考えられます。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/